Oracle Investment Management »

Cava Group Ord shares owned by Oracle Investment Management

Quarter-by-quarter ownership of Cava Group Ord (CAVA) shares owned by Oracle Investment Management from 13F filings

Historical chart of Oracle Investment Management investment in Cava Group Ord

Tip: Access up to 7 years of quarterly data

All positions including Cava Group Ord held by Oracle Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cava Group Ord by Oracle Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2M 18k 70.05

More positions owned by Oracle Investment Management

Biohaven (BHVN)
Springworks Therapeutics (SWTX)
Ardelyx (ARDX)
Genedx Holdings Corp Com Cl A (WGS)
Eyepoint Pharmaceuticals Com New (EYPT)
Walgreens Boots Alliance Call Call Option
Quidel Corp (QDEL)
Biohaven Call Call Option
Pacific Biosciences of California (PACB)
Forian Ord (FORA)
Spdr Ser Tr S&p Biotech Call Option (XBI)
BioCryst Pharmaceuticals (BCRX)
Springworks Therapeutics Call Call Option
Ardelyx Call Call Option
Staar Surgical Call Call Option

View all positions for Oracle Investment Management

Top funds holding Cava Group Ord

Artal Group
Vanguard Group
T. Rowe Price Investment Management
T. Rowe Price Associates
FMR
Conrad N. Hilton Foundation
D. E. Shaw & Co
Alliancebernstein
Susquehanna International
BlackRock
Citadel Advisors
Revolution Growth Management Company
Lord, Abbett & Co
Two Sigma Investments
Morgan Stanley

View all funds holding Cava Group Ord